Hsing-Ju (Cindy) Tsai

 

(530)752-5109
(530)752-1537

EDUCATION/TRAINING:

2002 B.S. in Department of Agricultural Chemistry, National Taiwan University, Taiwan, ROC
2003 - present Ph.D. candidate, Pharmacology and Toxicology, University of California, Davis

RESEARCH:

Pharmacokinetics of soluble epoxide hydrolase inhibitors
Effects of soluble epoxide hydrolase inhibitors and epoxyeicosatrienoic aicds on inflammatory disease

SELECTED PUBLICATIONS:

Kim IH, Nishi K, Tsai HJ, Bradford T, Koda Y, Watanabe T, Morisseau C, Blanchfield J, Toth I, Hammock BD. (2007). Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorg Med Chem. 15(1):312-23.

Xu D, Li N, He Y, Timofeyev V, Lu L, Tsai HJ, Kim IH, Tuteja D, Mateo RK, Singapuri A, Davis BB, Low R, Hammock BD, Chiamvimonvat N. (2006). Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A.

Christophe Morisseau, John W. Newman, Hsing-Ju Tsai, Preston A. Baecker and Bruce D. Hammock . (2006).Peptidyl-urea based inhibitors of soluble epoxide hydrolases. Bioorg Med Chem Lett. 16(20):5439-44.

Paul D. Jones, Hsing-Ju Tsai, Zung N. Do, Christophe Morisseau, and Bruce D. Hammock. (2006) Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 16(19):5212-6.

Ki Chang Ahn, Seung-Jin Ma, Hsing-Ju Tsai, Shirley J. Gee and Bruce D. Hammock An immunoassay for a urinary metabolite as a biomarker of human exposure to the pyrethroid insecticide permethrin. (2006). Anal Bioanal Chem. 384(3):713-22.

In-Hae Kim, Fenton R. Heirtzler, Christophe Morisseau, Kosuke Nishi, Hsing-Ju Tsai, and Bruce D. Hammock (2005). Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility. J Med Chem. 48(10):3621-9.